Tag: ANDA prioritization

The FDA's 2023-2025 overhaul of generic drug approvals prioritizes U.S.-made medications to fix supply chain gaps. Learn how the new pilot program speeds up approvals, impacts drug prices, and affects manufacturers and patients.